“Rising Adoption of Genetic Testing & Personalized Treatment Approaches for Rare Disorders”
- One key trend in the global oculodentodigital syndrome market is the increasing adoption of advanced genetic testing techniques, enabling early and accurate diagnosis of this rare congenital disorder
- Genetic testing helps identify mutations in the GJA1 gene, which is crucial for confirming ODDS and guiding tailored treatment strategies for affected individuals
- For instance, next-generation sequencing (NGS) and whole exome sequencing are increasingly utilized in clinical settings, significantly enhancing diagnostic accuracy and facilitating personalized care planning
- These advancements are accelerating early intervention, improving quality of life for patients, and fueling demand for precision diagnostics and individualized therapeutic approaches in the rare disease market
